Trial · NCT04396366
Results by group208
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 208
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline In Bacterial Load Colony-forming Units of Potentially Pathogenic Microorganisms in Sputum at Week 12 | QBW251 300 mg b.i.d | -0.192 | Standard Deviation 1.4621 | CFU/mL | |
| Change From Baseline In Bacterial Load Colony-forming Units of Potentially Pathogenic Microorganisms in Sputum at Week 12 | Placebo | 0.340 | Standard Deviation 1.6476 | CFU/mL | |
| Number of Participants With Absence of Any Colony-forming Units of Potentially Pathogenic Bacteria Sputum | QBW251 300 mg b.i.d | 0 | Participants | ||
| Number of Participants With Absence of Any Colony-forming Units of Potentially Pathogenic Bacteria Sputum | Placebo | 0 | Participants | ||
| Change From Baseline in Quality of Life Questionnaire for Bronchiectasis (QOL-B) (Respiratory Symptoms Domain) | QBW251 300 mg b.i.d | Day 28 n=12,19 | 5.247 | Standard Deviation 10.9936 | score on a scale |
| Change From Baseline in Quality of Life Questionnaire for Bronchiectasis (QOL-B) (Respiratory Symptoms Domain) | Placebo | Day 28 n=12,19 | 7.212 | Standard Deviation 9.5209 | score on a scale |
| Change From Baseline in Quality of Life Questionnaire for Bronchiectasis (QOL-B) (Respiratory Symptoms Domain) | QBW251 300 mg b.i.d | Day 56 n=12,20 | 1.852 | Standard Deviation 5.8026 | score on a scale |
| Change From Baseline in Quality of Life Questionnaire for Bronchiectasis (QOL-B) (Respiratory Symptoms Domain) | Placebo | Day 56 n=12,20 | 1.852 | Standard Deviation 11.7429 | score on a scale |
| Change From Baseline in Quality of Life Questionnaire for Bronchiectasis (QOL-B) (Respiratory Symptoms Domain) | QBW251 300 mg b.i.d | Day 84 n=13,20 | 2.849 | Standard Deviation 9.4612 | score on a scale |
| Change From Baseline in Quality of Life Questionnaire for Bronchiectasis (QOL-B) (Respiratory Symptoms Domain) | Placebo | Day 84 n=13,20 | 3.519 | Standard Deviation 11.9848 | score on a scale |
| Change From Baseline in Fibrinogen Plasma Concentration | QBW251 300 mg b.i.d | -0.193 | Standard Deviation 0.6278 | g/L | |
| Change From Baseline in Fibrinogen Plasma Concentration | Placebo | -0.127 | Standard Deviation 0.4828 | g/L | |
| Change From Baseline in Daily Rescue Medication Use (Salbutamol/Albuterol) | QBW251 300 mg b.i.d | -0.37 | Standard Deviation 1.069 | number of puffs | |
| Change From Baseline in Daily Rescue Medication Use (Salbutamol/Albuterol) | Placebo | 0.14 | Standard Deviation 0.895 | number of puffs | |
| Change From Baseline in Pre-bronchodilator Forced Exploratory Volume in the First Second (FEV1) | QBW251 300 mg b.i.d | Day 28 n=20,20 | -0.002 | Standard Deviation 0.1113 | liters |
| Change From Baseline in Pre-bronchodilator Forced Exploratory Volume in the First Second (FEV1) | Placebo | Day 28 n=20,20 | 0.012 | Standard Deviation 0.1541 | liters |
| Change From Baseline in Pre-bronchodilator Forced Exploratory Volume in the First Second (FEV1) | QBW251 300 mg b.i.d | Day 56 n=18,18 | 0.031 | Standard Deviation 0.1086 | liters |
| Change From Baseline in Pre-bronchodilator Forced Exploratory Volume in the First Second (FEV1) | Placebo | Day 56 n=18,18 | 0.007 | Standard Deviation 0.1137 | liters |
| Change From Baseline in Pre-bronchodilator Forced Exploratory Volume in the First Second (FEV1) | QBW251 300 mg b.i.d | Day 84 n=17,19 | 0.045 | Standard Deviation 0.1650 | liters |
| Change From Baseline in Pre-bronchodilator Forced Exploratory Volume in the First Second (FEV1) | Placebo | Day 84 n=17,19 | 0.022 | Standard Deviation 0.1260 | liters |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04396366/results